Bevacizumab
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
October, 2024
October 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Sep
Bevacizumab
Oct 18, 2024, 14:02 |
Drugs
The CityU iGEM Team is Back in 2024 - The Babak Lab
The Babak Lab shared a post on LinkedIn: "The CityU iGEM Team is Back in 2024!…
Oct 17, 2024, 17:51 |
Blog
Shahrin Ahmed: Liver Cancer Awareness Month
Shahrin Ahmed, Medical Specialist at Canadian Cancer Society, shared a post on X: ''Liver Cancer…
Oct 7, 2024, 15:38 |
Insight
Stephen V Liu: Afatinib and Bevacizumab in EGFR NSCLC
Stephen V Liu posted the following on X: “Phase II ABCD study of afatinib and…
Oct 4, 2024, 15:05 |
Insight
Iván R. González: Meta - analysis on the first-line treatment of NSCLC with EGFR mutation and brain metastases
Iván R. González, Medical Oncologist at Centro Oncológico Integral, Hospital Ángeles Puebla, shared on X:…
Oct 1, 2024, 09:55 |
Blog
María Natalia Gandur Quiroga: Promising Outcomes for Pazopanib Plus Bevacizumab in Clear Cell RCC
María Natalia Gandur Quiroga posted on X: "Promising Outcomes for Pazopanib Plus Bevacizumab in Clear…
Sep 8, 2024, 14:09 |
Insight
Article of the day, September 8th, suggested by the Immune Oncology Research Institute
Immune Oncology Research Institute shared a post on LinkedIn: “Article of the day! Suggest by the Immune…
Aug 27, 2024, 22:13 |
Insight
Stephen Liu: Final anaysis of WJOG9717L
Stephen Liu shared a post on X: “Final anaysis of WJOG9717L (phase II osimertinib +/-…
Aug 12, 2024, 21:46 |
Blog
GI cancers - rapid oral abstracs in ASCOBT 24 summarized by Erman Akkus
Erman Akkus, Medical Oncology Fellow at Ankara University Faculty of Medicine, shared on X: "GI…
Aug 6, 2024, 01:14 |
Blog
First-Line Maintenance Strategies for Ovarian Cancer with Bevacizumab and PARP Inhibitors - EIOC
Excellence in Oncology Care (EIOC) shared on X: "Save the Date! Join our virtual journal…
Jul 31, 2024, 07:32 |
Insight
Breaking Science in Gastrointestinal Cancers with David Tougeron - ESMO
ESMO shared on LinkedIn: "For ESMO members: Breaking Science in Gastrointestinal Cancers. David Tougeron discusses…
Jul 11, 2024, 09:55 |
Insight
Piotr Wysocki: Tisotumab vedotin improves outcomes of patients with recurrent cervical cancer
Piotr Wysocki recently posted on LinkedIn: "Vergote I et al. published results of a phase III…
Jul 11, 2024, 06:37 |
Insight
Results of the Complete Review on Targeted Therapies for Advanced Urothelial Carcinoma
María Natalia Gandur Quiroga shared on X: " Results and Main Messages of the Complete…
Jun 27, 2024, 02:53 |
Blog
Tanja Obradovic: Tempest Therapeutics just announced very good results from ongoing global clinical study with Amezalpat
Tanja Obradovic shared on LinkedIn: . “Are we to expect completely new mechanism of action…
Jun 20, 2024, 07:25 |
Blog
CityU iGEM - Great news from our recent meeting with Prof. Chun Kit Kwok
Maria Babak shared a post by CityU iGEM, on LinkedIn: "So cool that the strategy of…
Jun 19, 2024, 12:33 |
Blog
Maria Babak: How Bevacizumab is revolutionizing treatment for multiple cancers
Maria Babak shared a post by CityU iGEM on LinkedIn: "Discover how Bevacizumab, a powerful cancer…
Jun 16, 2024, 20:00 |
Insight
Daneng Li: SKYSCRAPER-14 a Phase III study on advanced hepatocellular carcinoma
Daneng Li, GI Medical Oncologist at City of Hope, shared on X/Twitter: "Out now, the…
Jun 15, 2024, 04:45 |
Blog
Discover the latest advancements in treating HER2-negative breast cancer brain metastases - Media Medic
Media Medic shared a post on LinkedIn: "ASCO China Voice | Professor Min Yan: Utidelone…
May 28, 2024, 14:22 |
Insight
Combination therapy significantly improves outcomes for patients with metastatic colorectal cancer - UCLA Health
Combining immune-targeted therapy with chemotherapy improves both progression-free survival and overall survival when compared to…
May 27, 2024, 07:37 |
Blog
Eric K. Singhi on BEAT-SC: Phase 3 Bev + Chemo/Atezo v Chemo/Atezo in 1L ES-SCLC
Eric K. Singhi shared the following on X: “BEAT-SC: Phase 3 Bev + Chemo/Atezo v Chemo/Atezo…
May 22, 2024, 01:03 |
Insight
Nicholas Hornstein: The first trial to demonstrate benefit of systemic therapy in appendiceal cancer
Nicholas Hornstein, Oncology Fellow at MD Anderson Cancer Centre, shared a post by Cancer Research…
May 8, 2024, 23:17 |
Insight
Giampaolo Bianchini: Join us at the next ESMO Virtual Plenary session!
Elisa Agostinetto, Research Physician at Institute of Jules Bordet in Brussels, shared a post by Giampaolo…
Mar 16, 2024, 20:07 |
Insight
Erman Akkus: HER2 and mCRC on Journal of Clinical Oncology
Erman Akkus, Medical Oncology Fellow at Ankara University, shared on X/Twitter: "HER2 and mCRC on…
Jan 5, 2024, 14:54 |
Blog
Pavlos Msaouel: Six papers that improved our understanding of Renal Medullary Carcinoma
Pavlos Msaouel, Assistant Professor of Genitourinary Medical Oncology at MD Anderson Cancer Center, recently posted…
Dec 26, 2023, 13:35 |
Insight
Erman Akkus: SUMMARIES OF 5 TOP-READ ARTICLES OF Journal of Clinical Oncology and JCO Precision Oncology in 2023!
Erman Akkus, Medical Oncology Fellow at Ankara University, shared on X/Twitter: "SUMMARIES OF 5 TOP-READ…
Nov 22, 2023, 02:57 |
Opinion
Ashley Love Sumrall: Must reads and often quoted at our tumor boards
Ashley Love Sumrall shared a post on X/Twitter: "I have praised the work of Shawn…
All:
25
Posts:
1 - 100
Making Personal Experience a Political Priority: Insights from EU Commissioner Stella Kyriakides
Zolbetuximab is now approved by the US FDA
Highlights from NFCR’s GSAC24
SIOP Honoured Hansjörg Riehm with the 2024 Lifetime Achievement Award
Margaret Foti has received the 2024 Beacon Award for Women Leaders in Oncology
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube